Elmwood Wealth Management’s Amedisys AMED Stock Holding History

Elmwood Wealth Management’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$1K	Hold	3	–	–	﹤0.01%	243
2020 Q2	$1K	Buy	+3	New	+$560	﹤0.01%	243

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Elmwood Wealth Management's AMED Position: Q3 2020 in Review

Elmwood Wealth Management held its Amedisys (AMED) position steady in Q3 2020 at 3 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #243.

Elmwood Wealth Management first reported a position in AMED in Q2 2020 and has held it in 2 quarters since. 397 funds tracked by Wall St. Rank hold AMED as of Q3 2020.

Elmwood Wealth Management held 3 shares of Amedisys worth $1K as of Q3 2020.
Elmwood Wealth Management left its Amedisys share count unchanged in Q3 2020.
Amedisys made up ﹤0.01% of Elmwood Wealth Management's portfolio in Q3 2020, its #243 holding.
Elmwood Wealth Management first reported a position in Amedisys in Q2 2020 and has held it in 2 quarters since.
397 funds tracked by Wall St. Rank held Amedisys as of Q3 2020.

Based on Elmwood Wealth Management's 13F filing for Q3 2020, filed 12 Nov 2020.